FDA Inspection
Gilead Sciences, Inc.Gilead Sciences, Inc. – FDA Inspection, Feb 12, 2024
Record Details
This FDA Inspection record concerns Gilead Sciences, Inc., with an inspection on February 12, 2024, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · ae4b768e-0f35-4f6a-8c5a-aa531e402a9d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1229435
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.188(b)(2)Identity of major equipment and lines used
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gilead Sciences, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2026 | VAI | Los Angeles District Office | Drug Quality Assurance |
| December 17, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gilead Sciences, Inc.
- FDA Inspection 1304734 - 2026-02-18
- FDA Inspection 1159086 - 2021-12-17
- FDA Inspection 1093610 - 2019-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.